B
VERA icon

Braidwell’s Vera Therapeutics VERA Stock Holding History

Braidwell’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24.2M Buy
564,724
+40,900
+8% +$1.52M 0.9% 45
2026
Q1 		$21.1M Sell
523,824
-260,918
-33% -$11.2M 0.7% 54
2025
Q4 		$39.7M Buy
784,742
+312,003
+66% +$11.1M 1.27% 31
2025
Q3 		$13.7M Buy
+472,739
New +$10.9M 0.41% 59

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Braidwell's VERA Position: Q2 2026 in Review

Braidwell increased its Vera Therapeutics (VERA) stake by 7.8% in Q2 2026, buying an estimated $1.52M and bringing the position to 564,724 shares worth $24.2M. The position accounts for 0.9% of the portfolio, ranked #45.

Braidwell first reported a position in VERA in Q3 2025 and has held it in 4 quarters since. The position peaked at $39.7M in Q4 2025. 219 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • Braidwell held 564,724 shares of Vera Therapeutics worth $24.2M as of Q2 2026.
  • Braidwell bought 40,900 Vera Therapeutics shares in Q2 2026, an estimated $1.52M.
  • Vera Therapeutics made up 0.9% of Braidwell's portfolio in Q2 2026, its #45 holding.
  • Braidwell first reported a position in Vera Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • Braidwell's Vera Therapeutics position peaked at $39.7M in Q4 2025.
  • 219 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Braidwell's 13F filing for Q2 2026, filed 14 Aug 2026.